Keyphrases
During Pregnancy
100%
United States
100%
Postnatal Exposure
100%
Antiretroviral
100%
In Utero Exposure
100%
Antiretroviral Agents
100%
Highly Active Antiretroviral Therapy (HAART)
80%
HIV-exposed
40%
Maternal Characteristics
40%
Surveillance Monitoring
40%
Protease Inhibitors
20%
AIDS/HIV
20%
Tenofovir
20%
Prenatal Exposure
20%
Viral Load
20%
Prospective Cohort Study
20%
Pediatric HIV
20%
Maternal HIV Infection
20%
Logistic Regression Model
20%
State-based
20%
HIV Viral Load
20%
Temporal Trends
20%
CD4 Count
20%
Toxicity Study
20%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
20%
Lamivudine
20%
Zidovudine
20%
Multivariable Logistic Regression
20%
Load Estimation
20%
Trend Characteristics
20%
Emtricitabine
20%
Early Timing
20%
Child Follow-up
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antiretrovirus Agent
100%
HIV
80%
Prospective Cohort Study
20%
Cohort Study
20%
Proteinase Inhibitor
20%
Prenatal Exposure
20%
Tenofovir
20%
RNA Directed DNA Polymerase Inhibitor
20%
Nonnucleoside Reverse Transcriptase Inhibitor
20%
Lamivudine
20%
Zidovudine
20%
Emtricitabine
20%
Virus RNA
20%